You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

72 search results for: type 2 inflammation

<b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis and Food Allergy

expert video

Type 2 Inflammation in Atopic Dermatitis and Food Allergy

1 min

Type 2 Inflammation

Watch this brief video as Dr. Peter Lio discusses the role of type 2 inflammation in the development of AD and food allergy.

<b>Type</b> <b>2</b> <b>Inflammation</b> and Its Role in Associated Dermatologic Diseases: A Two-Part Series

expert video

Type 2 Inflammation and Its Role in Associated Dermatologic Diseases: A Two-Part Series

30 min

Type 2 Inflammation

Join Dr. Raj Chovatiya as he reviews the pathophysiology and the role of type 2 inflammation in atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

42 min

Pulmonology

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

<b>Type</b> <b>2</b> <b>Inflammation</b> and Airway Remodeling Drive Lung Function Decline

videoanimation

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

4 min

Pulmonology

Explore the impact of type 2 inflammation and airway remodeling on lung function decline in asthma.

<b>Type</b> <b>2</b> <b>Inflammation</b> Digital Assessment Tool

interactivity

Type 2 Inflammation Digital Assessment Tool

4 min

Pulmonology

Learn how to assess patients for the presence of uncontrolled asthma driven by underlying type 2 inflammation.

The Pathophysiology of <b>Type</b> <b>2</b> <b>Inflammation</b> in CRSwNP

interactivity

The Pathophysiology of Type 2 Inflammation in CRSwNP

5 min

Rhinology

Learn how type 2 inflammation underlies the pathophysiology of CRSwNP.

Connecting <b>Type</b> <b>2</b> <b>Inflammation</b> to CRSwNP

expert video

Connecting Type 2 Inflammation to CRSwNP

1 min

Rhinology

Prof. Claus Bachert describes how type 2 inflammation drives CRSwNP.

Skin Barrier Dysfunction and <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis

videoanimation

Skin Barrier Dysfunction and Type 2 Inflammation in Atopic Dermatitis

2 min

Dermatology

Learn more about how the exaggerated immune response due to chronic and systemic type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis

expert video

Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis

10 min

Dermatology

In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.

<b>Type</b> <b>2</b> <b>Inflammation</b> Is a Significant Driver of Pediatric Severe Asthma

Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

5 min

Pulmonology

Learn about the role of type 2 inflammation in the burden and pathophysiology of severe asthma in pediatric patients

FeNO: A Biomarker of <b>Type</b> <b>2</b> <b>Inflammation</b> in Pediatric Asthma Patients

Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

5 min

Pulmonology

Learn about the role of FeNO as a noninvasive test to identify type 2 inflammation in pediatric patients with asthma.

<b>Type</b> <b>2</b> <b>Inflammation</b> and Infections

slide presentation

Type 2 Inflammation and Infections

15 min

Type 2 Inflammation

This slide deck will provide an overview of the concepts of type 1, type 2, and type 3 immune responses.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region